News

Recent News About Hesperos and Human-on-a-Chip Technology

Hesperos Human-on-a-Chip Technology Awarded $4 Million Phase IIb SBIR Grant – the first tissue chip company to receive Phase IIb grant

By Hesperos | September 6, 2018 | 0 Comments

ORLANDO, FLA – September 6, 2018 — Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center … Read More

Hesperos To Create Multi-Organ Human-On-A-Chip Model to Test Alzheimer’s Drugs

By Hesperos | August 31, 2018 | 0 Comments

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” … Read More

UniChip paper selected as top 10% of papers published in Lab on a Chip

By Hesperos | August 21, 2018 | 0 Comments

Dr. Shuler’s “UniChip enables long-term recirculating unidirectional perfusion with gravity-driven flow for microphysiological systems” has been selected by the handling Editor as one of the top 10% of papers published in Lab on a Chip. This selection … Read More

Hesperos, Inc. Among GrowFL Florida Companies to Watch Finalists

By Hesperos | August 16, 2018 | 0 Comments

(ORLANDO, Fla.)  Hesperos, Inc. has announced that it is among the first round of finalists for the 2018 Florida Companies to Watch honor, recently announced by GrowFL.  The awards event – now in its eighth year – honors … Read More

First Functional Stem-Cell Derived Neuromuscular Junction Model Licensed

By Hesperos | April 25, 2018 | 0 Comments

ORLANDO, FLA – April 25, 2018 — Hesperos, Inc. has increased its pioneering human-on-a-chip drug testing capabilities by adding a new in vitro, human-human neuromuscular model to its patented multi-organ microfluidic device systems. Abnormal function of … Read More

Overcoming a Big Barrier: Hesperos CEO awarded for Blood-Brain Barrier Innovation

By Hesperos | March 19, 2018 | 0 Comments

Getting drugs past the neuroprotective blood-brain barrier (BBB) has been a perplexing problem and formidable challenge for researchers and pharmaceutical companies alike. Hesperos’s creation of a microfluidic model capable of mimicking in vivo characteristics of the … Read More

Hesperos Multi-Organ System Featured in Science

By Hesperos | March 14, 2018 | 0 Comments

The challenge: Build microfluidic devices that can keep cells alive in a setting that mimics specific organs or tissues, and incorporate biosensors to measure the cells’ physiology. The goal: Mimic diseases and test drug responses that … Read More